Twist Bioscience (($TWST)) has held its Q4 earnings call. Read on for the main highlights of the call. Twist Bioscience’s recent earnings call ...

Researchers from Turku Bioscience Center at the University of Turku, Finland, have developed a new computational method to ...

Twist Bioscience reports mixed Q4 earnings with a loss of 45 cents, sales of $99.01 million beating consensus.

Aytu BioScience (($AYTU)) has held its Q1 earnings call. Read on for the main highlights of the call. Aytu BioScience’s recent earnings call ...

Analysts expect the South San Francisco, California-based company to report quarterly loss at 50 cents per share, versus a ...

Twist Bioscience recently reported fourth-quarter and full-year fiscal 2025 results, highlighting record revenue of US$99.01 million and strong double-digit growth across synthetic biology, biopharma, ...

Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to end the morbidity and mortality of aging, today announced the release of new research detailing an ...

Before becoming the Unabomber, Ted Kaczynski underwent intense psychological experiments at Harvard. Experts question if these studies influenced his bombing spree.  Read More ...

Still, the recently released 2025-30 Arizona Bioscience Roadmap, as well as several academic, community and local government leaders, indicate that Arizona's 2002 investment in TGEN has lived up to ...

HOLLISTON, Mass. (AP) — HOLLISTON, Mass. (AP) — Harvard Bioscience Inc. (HBIO) on Thursday reported a loss of $1.2 million in its third quarter. The Holliston, Massachusetts-based company said it had ...

Discover Q3 2025 earnings insights for Harvard Bioscience—learn about margin gains, product launches, and demand trends.

The goal of the project is to develop novel approaches that strengthen and reduce the costs of domestic mAb biomanufacturing to protect against and treat infection by filoviruses.